LENZ THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
LENZ THERAPEUTICS, INC. (LENZ) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $30.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $30.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $43.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $57.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $75.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $43.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $57.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $75.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $95.00K 10-Q · filed 2025-07-30 |
| 2025-03-31 | $117.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $141.00K 10-K · filed 2025-03-19 |
| 2024-09-30 | $168.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $196.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $23.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $20.00K 10-K · filed 2024-02-27 |
| 2023-09-30 | $33.38M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $34.81M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $276.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $380.00K 10-K · filed 2023-03-20 |
| 2022-09-30 | $510.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $666.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $852.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.07M 10-K · filed 2022-03-21 |
| 2021-09-30 | $968.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |